Cleerly LABS vs Eko Low Ejection Fraction Tool (ELEFT)
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if you require a detailed, quantitative assessment of coronary artery disease using CCTA imaging. This tool is ideal for precisely characterizing plaque volume and type, quantifying stenosis, and tracking disease progression over time to inform personalized treatment strategies for patients with known or suspected coronary atherosclerosis.
View Cleerly LABS →Choose Eko Low Ejection Fraction Tool (ELEFT) if…
Choose Eko Low Ejection Fraction Tool (ELEFT) if you need a rapid, non-invasive screening method for early detection of low ejection fraction during routine physical examinations. This tool is best suited for primary care physicians or cardiologists looking to quickly identify patients at risk for heart failure using an integrated digital stethoscope, enabling timely referrals for further diagnostic workup.
View Eko Low Ejection Fraction Tool (ELEFT) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Pricing | Varies | Unknown |
| Deployment | Cloud, On-premise | Unknown |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Low Ejection Fraction Tool (ELEFT)Eko Low Ejection Fraction Tool (ELEFT) offers superior usability for routine clinical workflows, integrating seamlessly with digital stethoscopes to provide rapid results in approximately 15 seconds during physical exams. Its 'super user-friendly' design and 100% staff satisfaction in a case study highlight its ease of adoption at the point of care.
Clinical Value
Cleerly LABSCleerly LABS provides a more comprehensive and detailed diagnostic assessment of coronary artery disease, including quantitative analysis of plaque, stenosis, and ischemia, with the ability to track disease progression. This depth of analysis offers novel clinical insights for personalized heart disease management and aims to eliminate heart attacks.
Pricing & Value
Cleerly LABSCleerly LABS offers transparent per-analysis pricing and has achieved a Category I CPT code (75577) with a defined global reimbursement rate of $1,026, effective January 1, 2026, indicating established value and clearer reimbursement pathways. ELEFT's 'contact for pricing' model and Category III CPT code make its cost-value proposition less transparent and potentially more complex for reimbursement.
Enterprise Readiness
Cleerly LABSBoth tools are FDA-cleared, HIPAA compliant, and cloud-based. However, Cleerly LABS provides more explicit details on its integration capabilities with PACS, RIS, and EHR systems via its Cleerly Proxy and PowerScribe integration, which are crucial for seamless workflow integration in imaging-heavy enterprise environments.
Innovation
Cleerly LABSWhile both are innovative, Cleerly LABS demonstrates a higher degree of innovation by applying advanced AI to complex CCTA imaging for detailed, quantitative plaque characterization, stenosis, and ischemia detection, aiming to create a new standard of care for heart attack prevention. ELEFT innovates by bringing AI to a point-of-care device, but Cleerly's ambition to fundamentally change CAD management through deep imaging analysis gives it a slight edge.
Support & Docs
Eko Low Ejection Fraction Tool (ELEFT)Eko Health provides more comprehensive and structured support resources, including a dedicated SENSORA Help Center with specific sections for various user roles, user manuals, FAQs, and specialized clinical enablement and reimbursement support teams. Cleerly mentions general support hours, but Eko's offerings appear more detailed and tailored for enterprise adoption.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Tool Name | Cleerly LABS | Eko Low Ejection Fraction Tool (ELEFT) |
| Company | Cleerly | Eko Health |
| Description | AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. | FDA-cleared AI algorithm that integrates with Eko digital stethoscopes to aid clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams. |
| Primary Function | Comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, ischemia detection (with Cleerly ISCHEMIA module), and personalized heart disease risk assessment. | AI-powered low ejection fraction detection by analyzing ECG and heart sound recordings. |
| Input Data | Coronary CT angiography (CCTA) images. | ECG and heart sound recordings from Eko digital stethoscopes. |
| Specialties | Cardiology, Radiology | Cardiology, Family Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and Eko Low Ejection Fraction Tool (ELEFT).
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or Eko Low Ejection Fraction Tool (ELEFT)
Backers
Who funded each tool's parent company.